New “Legal Highs” On The Rise

Amateur chemists are creating new recreational drugs at such a rate that governments cannot keep up.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Half a gram of JWH-018, a synthetic cannabinoidWIKIMEDIA, PSYCHONAUGHTThe creation, supply, and use of new synthetic drugs is on the rise across the Western world and governments are struggling to keep track and regulate the variety of substances, according to a report from the United Nations Office on Drugs and Crime (UNODC).

Some of these “designer drugs” have hit the headlines but there are hundreds more on the market, and amateur chemists in professional-standard home laboratories are developing new substances all the time. Indeed, the European Monitoring Center from Drugs and Addiction reported 73 new drugs in 2012—with new substances arriving on the market at a rate of more than one a week.

In Britain, the UNODC report said, almost 700,000 people aged between 15 and 24 have experimented with these “legal highs,” though the report adds that the biggest market is the United States, where use of the substances “appears to be more than twice as widespread as in the European Union.”

Sold openly on the Internet under euphemistic descriptions such as “bath salts,” “incense,” and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies